Déterminants de la distance parcourue et de la dyspnée lors du test de marche de six minutes chez les patients atteints de BPCO

Bruyneel, Marie; Jacob, V.; Sanida, C.; Ferrali, O.; Ameye, Lieveke; Ninane, Vincent; Sergysels, Roger

doi:10.1016/j.rmr.2012.08.004

Cited by 4 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 50 people with COPD and mean FEV1 45% predicted, the reduction in inspiratory capacity following a 6MWT was associated with the change in modified Borg score during the test (r 2 50.21, p,0.0006) [146]. Other studies have reported close relationships between modified Borg scores during the 6MWT in COPD and the severity of dyspnoea during daily life (r50.54) [147] and HRQoL (r5 -0.69--0.43) [58,148].…”

Section: Dyspnoeamentioning

confidence: 86%

“…A wide variety of independent predictors of 6MWD were identified, with no consistency within or between disease groups (tables S21 and S22) [19,30,32,50,51,58,60,64,82]. These models predicted between 20% and 70% of the variation in 6MWD, suggesting that there are other contributors to 6MWD that have not yet been defined.…”

Section: Multivariate Models For Predicting 6mwdmentioning

confidence: 99%

“…There were no discernible differences between patient groups. Relationship of 6MWD to disease severity There were weak to moderate correlations between 6MWD and measures of disease severity such as FEV1 (in COPD; correlation coefficients 0.31-0.70) (table S16) [17,[30][31][32][50][51][52][53][54][55][56][57][58], forced vital capacity (FVC) or diffusing capacity of the lung for carbon monoxide (DLCO) (in ILD and SSc; correlation coefficients 0.06-0.61) (tables S17 and S18) [12,23,[59][60][61][62][63][64][65]. In COPD, two studies reported that the relationship between FEV1 and 6MWD was stronger in more severe disease [54,66].…”

Section: Is the 6mwt A Maximal Test?mentioning

confidence: 99%

“…Relationship of 6MWD to patient-reported outcomes Although the 6MWD was consistently associated with symptoms and health-related quality of life (HRQoL) across all disease groups, these relationships were generally of weak to moderate strength (correlation coefficients 0.01-0.65) (tables S19 and S20) [17,19,30,32,42,50,51,56,58,61,62,67,70,71].…”

Section: Is the 6mwt A Maximal Test?mentioning

confidence: 99%

See 3 more Smart Citations

An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease

Singh¹,

Puhan²,

et al. 2014

View full text Add to dashboard Cite

This systematic review examined the measurement properties of the 6-min walk test (6MWT), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT) in adults with chronic respiratory disease.Studies that report the evaluation or use of the 6MWT, ISWT or ESWT were included. We searched electronic databases for studies published between January 2000 and September 2013.The 6-min walking distance (6MWD) is a reliable measure (intra-class correlation coefficients ranged from 0.82 to 0.99 in seven studies). There is a learning effect, with greater distance walked on the second test (pooled mean improvement of 26 m in 13 studies). Reliability was similar for ISWT and ESWT, with a learning effect also evident for ISWT (pooled mean improvement of 20 m in six studies). The 6MWD correlates more strongly with peak work capacity (r50.59-0.93) and physical activity (r50.40-0.85) than with respiratory function (r50.10-0.59). Methodological factors affecting 6MWD include track length, encouragement, supplemental oxygen and walking aids. Supplemental oxygen also affects ISWT and ESWT performance. Responsiveness was moderate to high for all tests, with greater responsiveness to interventions that included exercise training.The findings of this review demonstrate that the 6MWT, ISWT and ESWT are robust tests of functional exercise capacity in adults with chronic respiratory disease. OverviewThe aim of this systematic review was to examine the measurement properties for the 6-min walk test (6MWT), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT) in adults with chronic respiratory disease. A companion paper describes the standard operating procedures for the tests [1]. The key findings of this systematic review are as follows.1) The 6-min walking distance (6MWD) is a valid and reliable measure of exercise capacity for people with chronic lung disease. The 6MWD correlates more strongly with measures of peak work capacity and physical activity than with respiratory function or quality of life, which supports its conceptualisation as a test of functional exercise performance.2) The ISWT offers a different protocol to the 6MWT as it is incremental and externally paced. The ISWT is a valid and reliable measure of cardiopulmonary exercise capacity in chronic obstructive pulmonary disease (COPD), where there is a strong relationship between ISWT distance and peak oxygen uptake (V9O 2 peak) or work rate on a cardiopulmonary exercise test (CPET).3) A learning effect is observed for the 6MWT and the ISWT. The second test usually is the better compared with the first, but this is inconsistent.4) The ESWT is a test of endurance capacity. It is externally paced and is performed along the same course as the ISWT. Two tests do not appear to be necessary if the second test is conducted on the same day.5) Reference equations have been proposed for the 6MWD and the ISWT. Age, height and weight are included in most equations. The influence of race and ethnicity is unclear.6) The safety profile of ...

show abstract

Section: Dyspnoeamentioning

confidence: 86%

Section: Multivariate Models For Predicting 6mwdmentioning

confidence: 99%

Section: Is the 6mwt A Maximal Test?mentioning

confidence: 99%

Section: Is the 6mwt A Maximal Test?mentioning

confidence: 99%

See 2 more Smart Citations

An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease

Singh¹,

Puhan²,

et al. 2014

View full text Add to dashboard Cite

show abstract

Inter-rater reliability and agreement of 6 Minute Walk Test and 10 Meter Walk Test at comfortable walk speed in patients with acute stroke

Busk

Holm

Skou

et al. 2022

Physiotherapy Theory and Practice

View full text Add to dashboard Cite

The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension

et al. 2016

View full text Add to dashboard Cite

Using distributional and anchor-based methods, we estimate the minimum important difference for Borg dyspnea scale in pulmonary arterial hypertension is approximately 0.9 units. Using distributional methods only, we estimate the minimum important difference for the Borg fatigue scale is around 1 unit. Further studies are needed to determine the clinical utility of these scores in patients with pulmonary arterial hypertension.

show abstract

Déterminants de la distance parcourue et de la dyspnée lors du test de marche de six minutes chez les patients atteints de BPCO

Cited by 4 publications

References 17 publications

An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease

An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease

Inter-rater reliability and agreement of 6 Minute Walk Test and 10 Meter Walk Test at comfortable walk speed in patients with acute stroke

The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension

Contact Info

Product

Resources

About